首页> 外文期刊>Rejuvenation research >Cell squeezing: A vector-free microfluidic platform for intracellular delivery of molecules
【24h】

Cell squeezing: A vector-free microfluidic platform for intracellular delivery of molecules

机译:细胞挤压:无载体的微流控平台,用于分子内细胞内递送

获取原文
获取原文并翻译 | 示例
           

摘要

Alzheimer disease (AD) is a progressive neurodegenerative disorder characterized by the accumulation of amyloid plaques and tangles and the loss of neurons in the brain. Many risk factors lead to the development of AD. The disruption of more than one protein activity may be responsible for the late-onset form of AD. Plaques are composed of aggregated fibrils of beta-amyloid (fAbeta) and are surrounded by microglia, the immune response cells of the central nervous system (CNS). Microglia internalize fAbeta and deliver it to their lysosomes, but do not completely degrade it. The lysosomal pH of microglia is higher than that of macrophage cells, and this may decrease the lysosomal enzyme activity. Microglia treated with macrophage colony-stimulating factor (MCSF) have a lower lysosomal pH and degrade fAbeta more efficiently than untreated microglia.
机译:阿尔茨海默氏病(AD)是一种进行性神经退行性疾病,其特征是淀粉样斑块和缠结的积累以及大脑中神经元的丢失。许多风险因素导致AD的发展。超过一种蛋白质活性的破坏可能是AD晚期发作的原因。斑块由β-淀粉样蛋白(fAbeta)的聚集原纤维组成,被小胶质细胞包围,小胶质细胞是中枢神经系统(CNS)的免疫反应细胞。小胶质细胞将fAbeta内在化并将其递送至其溶酶体,但并未完全降解。小胶质细胞的溶酶体pH高于巨噬细胞,可能会降低溶酶体酶的活性。与未处理的小胶质细胞相比,用巨噬细胞集落刺激因子(MCSF)处理的小胶质细胞具有较低的溶酶体pH值,并能更有效地降解fAbeta。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号